CALL FOR ABSTRACTS — 141st APHA Annual Meeting

Theme: Think Global, Act Local: Best Practices Around the World

Cancer Forum

Submission Deadline: Thursday, February 7, 2013


The Cancer Forum invites abstracts for oral presentations, symposia, and posters describing original research and innovative intervention programs or policies that address topics including behavioral, genetic, socioeconomic, and environmental risk factors for cancer; prevention and early detection; cancer treatment outcomes; clinical trials; cancer disparities; cancer literacy and cancer communication; and cancer survivorship. Special consideration will be given to research pertaining to this year’s conference theme, “Think Global, Act Local: Best Practices Around the World.” Potential topics include:
  • Advances and issues in cancer screening and new best practices
  • Behavioral and policy interventions related to human papillomavirus vaccination among female and male adolescents and young adults for the prevention of cervical, anogenital, and oral cancers
  • Cancer prevention among women including the promotion of age-appropriate cancer screenings, healthy eating and exercise, and smoking prevention/cessation
  • Cancer survivorship research among all age groups, particularly as it relates to recurrence, risk reduction, and maintaining health and wellness following a cancer diagnosis
  • Childhood, youth, young adult, and adult behaviors that impact the risk of cancer later in life through old age, including tobacco use, poor diet, physical inactivity, excessive sun exposure, infection with the human papillomavirus, excessive alcohol use, etc. and innovative interventions or policies aimed at changing these high-risk behaviors
  • Cultural issues in cancer prevention and control (e.g., stigma related to cancer)
  • Economic evaluation of cancer prevention and cancer care
  • Exploration of the public health impact of rapidly emerging discoveries and technologies in genetics and gene-environment interactions in cancer risk and prevention and the need for public education related to these changes
  • Global health issues in cancer prevention, control, and survivorship with an emphasis on developing and newly industrialized countries
  • Global outreach for cancer prevention through community health workers
  • Innovative social media, web 2.0, and other new technological interventions to promote cancer prevention, screening, treatment, or survivorship
  • Innovative strategies to increase recruitment of minority and medically underserved populations to cancer prevention, screening, and treatment clinical trials
  • Neighborhood contextual factors and community organizing related to cancer prevention, screening, and treatment
  • Patient navigation, peer navigation, and/or healthcare delivery changes/models to improve delivery of and/or promote best practices in cancer screening, treatment and survivorship services
  • Screening for smoking-related cancers including lung cancer and oral cancer
  • Social determinants (conditions in which people are born, grow, live, work and age) and their impact on the risk of cancer and innovative interventions or policies aimed at improving these conditions
  • The interconnectedness of poverty and cancer among women and other vulnerable (e.g., LGBT, low-SES, medically ill) populations
  • Translation of clinical and other best practices into global health policy and/or the utilization of global health policy to advance country-level practices in cancer prevention and control
Abstracts are limited to 250 words or less. They will be evaluated based on their conceptual and methodological quality, innovation and novelty, and relevance. Abstracts are required to include quantitative or qualitative data. Preliminary data are acceptable. Referral to web pages or URLs may not be used for abstracts. An author may not submit the same abstract to more than one Section, SPIG, Caucus or Forum. For any and all inquiries about your abstract, always refer to the abstract number assigned to you by the online system. Oral presentations at contributed sessions are generally 13-15 minutes in length. An additional 3-5 minutes will be available for discussion and questions from the audience.

Presenters at poster sessions should display their work and be available to answer questions throughout the scheduled 60 minute poster session. Preferences for oral versus poster presentation will be considered, but the program committee will consider all abstracts for both oral and poster categories. If you are interested in submitting a panel/symposium for consideration as part of the 2013 APHA Cancer Forum program, please contact the Program Planners (jirvinvidrine@mdanderson.org and vani.simmons@moffitt.org) for additional instructions.

Continuing Education Credit: APHA values the ability to provide continuing education credit to physicians, nurses, health educators, and those certified in public health at its annual meeting. Please complete all required information when submitting an abstract so members can claim credit for attending your session. These credits are necessary for members to keep their licenses and credentials. For a session to be eligible for Continuing Education Credit, each presenter, panelist, discussant, and/or faculty must provide:

1)      an abstract free of trade and/or commercial product names;

2)      at least one MEASURABLE SINGLE objective (“to understand” or “to learn” are not measurable objectives and compound objectives are not acceptable). Use ONLY the following Measurable Action Verbs: Explain, Demonstrate, Analyze, Formulate, Discuss, Compare, Differentiate, Describe, Name, Assess, Evaluate, Identify, Design, Define or List.

3)      A signed Conflict of Interest Disclosure Form with a relevant qualification statement; Example of Acceptable Biographical Qualification Statement: (I have been the principal or co-principal of multiple federally funded grants focusing on the epidemiology of drug abuse, HIV prevention and co-occurring mental and drug use disorders. Among my scientific interests has been the development of strategies for preventing HIV and STDs in out-of-treatment drug users.)

4)      All continuing education learning content must be of sound science or professional practice and serve to maintain, develop, or increase the knowledge, skills and professional competence of the health professional. Learning content should be evidence-based if available. A list of over 30 areas will be provided online for you to choose from. You will be asked to choose at least one or up to 6 areas that your presentation will address. Thank you for your assistance in making your session credit worthy. Contact Annette Ferebee at annette.ferebee@apha.org if you have any questions concerning continuing education. For program questions, contact the program planners listed below.

Program Planner Contact Information:
Jennifer Irvin Vidrine, PhD
Department of Health Disparities Research
UT MD Anderson Cancer Center
Unit 1440, PO Box 301402
Houston, TX 77230-1402
Phone: 713-745-2383
JIrvinVidrine@mdanderson.org

and

Vani Nath Simmons, Ph.D.
Assistant Member
Tobacco Research & Intervention Program
Assistant Professor
Departments of Oncologic Sciences & Psychology
Phone: 813-745-4816
vani.simmons@moffitt.org


Ready?
Program Planner Contact Information:
Jennifer Vidrine, PhD
Department of Health Disparities Research
UT MD Anderson Cancer Center
1400 Pressler St., Unit 1440
Houston, TX 77030-3906
Phone: 713-745-2383
JIrvinVidrine@mdanderson.org

and
Vani Simmons, Ph.D.
Moffitt Cancer Center
vani.simmons@moffitt.org